[1]
Jayanthi, C.R., S., S.A., Shankar, M.R., S. P. T., L.P., L., M.R. and K., R.T. 2021. A prospective, open label, randomized-controlled study to evaluate the efficacy and safety of MyVir tablets in mildly symptomatic COVID-19 patients. International Journal of Basic & Clinical Pharmacology. 10, 8 (Jul. 2021), 967–975. DOI:https://doi.org/10.18203/2319-2003.ijbcp20212926.